PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and small-molecule drugs. It offers Ataluren, an orally administered small-molecule investigational new drug for the treatment of cystic fibrosis and duchenne muscular dystrophy caused by nonsense mutations. The company also provides PTC299, an anti-angiogenesis drug for the treatment of metastatic breast cancer, multiple tumors, and neurofibromatosis. Its products are used for the treatment of genetic disorders, oncology, and infectious diseases. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.

Athena Diagnostics, Inc. provides clinical diagnostics testing laboratory services. The firm focuses on neurology, endocrinology, hearing loss and nephrology. It offers tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. The company was founded in 1988 and is headquartered in Marlborough, MA.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Develops and manufactures drugs related to immunology, neurobiology and oncology

Tianjin Huada Medical Laboratory Co., Ltd., established on 2014-10-09, Business scope includes licensed projects:medical service;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).General project:Medical Research and Experimental Development;Import and export;Technology Import and Export;Import and export agency;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Experimental analysis instrument sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Retailing of computer software, hardware and auxiliary equipment;Sales of Class II Medical Devices;housing lease;Non-residential real estate leases.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

BGI Genomics Co., Ltd. is a holding company that engages in development of science and technology services in genomics field. Its business scope ranges from scientific, health, agricultural and informatics. The company was founded by Wang Jian on September 9, 1999 and is headquartered in Shenzhen, China.

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.

Guangzhou Huada Gene Medical Laboratory Co., Ltd., established on 2014-01-27, Business scope includes sales of Class I medical devices;Chemical product sales(No licensed chemical products);Medical Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Office Equipment Sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Experimental analysis instrument sales;Instrument sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Office equipment rental service;Medical equipment rental;Non-residential real estate leases;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Domestic trade agent;Technology Import and Export;Import and export agency;Import and export;Class III medical device business;medical service;

BGI Biotechnology (Wuhan) Co., Ltd., established on 2013-10-31, Business scope includes biotechnology products,medical instruments,Research and development of laboratory equipment;First,two,Production, wholesale and retail of Class III medical devices;Consumables for biological research,Reagent,Wholesale and retail of instruments;biotechnology research,technical consulting,technology transfer,Technical Services;Import and export,Technology Import and Export(Goods and technologies prohibited by the state from import and export are not included);production class;6840In vitro diagnostic reagents,6840Clinical laboratory analysis equipment production category II:6870Three categories of medical software production:6840In vitro diagnostic reagents.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jabrehoo focusing on clinical transformation and innovative research and development of related products in the field of assisted reproduction, genetics and eugenics, providing one-stop solutions for reproductive genetics for assisted reproduction couples, infertile patients, and people who are preparing for pregnancy, and promoting the localization of various detections.

Counsyl is a health technology company that offers DNA screening for men, women and their children. Our philosophy is simple - focus on diseases where advanced knowledge makes a difference in health outcomes, whether it's changing a behavior, pursuing preventative measures, or simply preparing for what lies ahead. Counsyl has screened over 500,000 patients and served over 6,000 health professionals in its modern clinical laboratory. From the purely mechanical to profoundly human, Counsyl strives to make DNA screening truly accessible to everyone. The team consists of world class engineers, scientists and clinical experts as well as a renowned engineering and scientific advisory board. Counsyl integrates sophisticated technology with custom robotic automation in its accredited medical laboratory. This focus on technology has made Counsyl a leader in helping patients and doctors communicate about medical results in real time. Its products have won the Wall Street Journal’s Innovation Award for Medicine, and have been named one of Scientific American's "Top 10 World Changing Ideas." Counsyl’s Family Prep Screen has already helped hundreds of thousands of people discover critical information before having children, and the Counsyl platform now extends beyond family preparation to include informed pregnancy and cancer screening.

Shandong Shanda Affiliated Reproductive Hospital Co., Ltd., established on 2010-01-26, The scope of business includes surgery within the scope of license approval,Obstetrics and Gynecology,Anesthesiology,Medical Laboratory,medical imaging,Diagnosis and treatment services of Chinese medicine department;Human Assisted Reproductive Technology and Human Sperm Bank Training.(The validity period is subject to the license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Tianlong Technology is an innovation driven high-tech enterprise that takes the market as the guide, industry, education and research as the basis, and pursues its own brand. Since its establishment in 1997, the company has always adhered to the development philosophy of serving the public with science and technology, taking the market as the guide and taking customers as the center, and is committed to the research, development, production and sales of instruments and in vitro diagnostic reagents in the field of gene detection and molecular diagnosis. Tianlong will continue to pay attention to customer needs, respond quickly, and serve medical diagnosis, scientific research, biological testing, personalized medicine, independent laboratories, food safety, inspection and quarantine and other fields with increasingly perfect services and excellent products. Facing the opportunities and challenges in the future, Tianlong will work together with all sectors in a more open way of cooperation to create first-class molecular diagnostic products for human health with the mission of building a national brand. The new Tianlong will continue to take the responsibility and feelings of corporate citizens, uphold the spirit of excellence, self-reliance, honor and responsibility, and make unremitting efforts to build Tianlong into an international famous enterprise in the field of molecular diagnosis!

Chigene is a developer of a cloud-based diagnostic platform for genetic diseases. Their diagnostic platforms include Quanpubao for genetic disease and gene carrier screening, spectrum screening for newborn genetic disease screening, and quanpuan for early cancer prevention monitoring.

Genetics Generation Advancement Corp. engages in the provision of genetic testing, molecular diagnostics, biotechnology services, personal health-related testing services, biological information services, and health care services. It offers testing, pre-implantation stage, prenatal stage, newborn medical examination, adult healthcare health management genetic testing, adult healthcare cancer pharmacogenetics testing and other related testing services. The company was founded on November 21, 2008 and is headquartered in Taipei, Taiwan.

Shenzhen Huada Clinical Laboratory Co., Ltd., part of BGI Genomics Co., Ltd., is a company headquartered in Shenzhen, China, that operates medical laboratory. The firm was founded in 2012. Li Jian Zhao is the current CEO of the company.

Beijing Zhiyin Oriental Diagnostic Technology Co., Ltd., established on 2020-09-27, Business scope includes technology development;Technology Promotion;Technical Services;software development;Sales of medical devices(Ι,Class II),Instrumentation,computer,Software and Auxiliary Equipment;Import and export;Technology Import and Export;Agent import and export;Production of medical devices Class I;Sales of Class III Medical Devices;Production of the second class,Class III medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sales of Class III Medical Devices,Production of the second class,Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)